SUPRAX

Denton Pharma, Inc. DBA Northwind Pharmaceuticals🇺🇸 United States

FDA Page

Effective Date: Dec 27, 2019
Approval ID: 655a59ba-08e9-51d4-e053-2991aa0aef34
Products: 1 registered
Version: 2

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use SUPRAX® safely and effectively. See full prescribing information for SUPRAX®. SUPRAX® (cefixime) tablets, for oral use SUPRAX® (cefixime) capsules, for oral use SUPRAX® (cefixime) chewable tablets, for oral use SUPRAX® (cefixime) for oral suspension Initial U.S. Approval: 1986

Quick Stats

Total Products1

Labelers2

Label Sections19

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.